Following the discovery of BRAF mutations in human cancers in 2002, Tamihiro and colleagues expanded their transgenic animal studies to include BRAFV600E-driven cancer models, in collaboration with Prof. Martin McMahon (Kamata et al., 2013). Here, BRAF is linked to cancer.